Performance Enhancing Drugs and Blood Doping
Performance-Enhancing Drugs in Sport
Performance-enhancing drugs (PEDs) are substances that athletes take to improve their physical or psychological output in training or competition. Most PEDs are prohibited by the World Anti-Doping Agency (WADA) and the governing bodies of individual sports. The use of prohibited substances is considered cheating because it undermines the principle of fair competition and often poses serious health risks to the performer. Despite this, doping remains a persistent problem across numerous sports at elite level. Understanding which categories of PED exist, why performers use them and the consequences they carry is essential both for the exam and for understanding the ethical landscape of modern sport.
Stimulants
Stimulants are substances that increase alertness, reduce the sensation of fatigue and heighten aggression and competitiveness. They can improve reaction time and allow a performer to sustain high-intensity effort for longer. Sports such as sprint cycling or combat sports, where aggression and alertness are direct performance assets, have seen stimulant abuse. Side effects include elevated heart rate, anxiety, insomnia and in severe cases heart attack. Stimulants are banned in competition by most governing bodies.
Narcotic Analgesics
Narcotic analgesics are powerful painkillers that reduce or eliminate the sensation of pain. Performers who have sustained injuries, or who train at a very high volume (which inevitably produces chronic discomfort), may be tempted to use narcotic analgesics to continue competing. The critical danger is that pain is the body’s warning signal. A performer who cannot feel pain is at serious risk of worsening an existing injury, potentially causing long-term damage to tendons, ligaments or bones. Side effects include dependency, nausea and loss of coordination.
Anabolic Agents
Anabolic agents, commonly called anabolic steroids, are synthetic hormones that accelerate the development of muscle mass and reduce recovery time between training sessions. They are most commonly associated with power-based sports such as weightlifting, shot put or rugby, where muscle mass is a direct determinant of performance. By allowing performers to train harder and recover faster, anabolic agents provide a substantial competitive advantage. Side effects include liver damage, cardiovascular disease, hormonal disruption (including in secondary sexual characteristics) and, in adolescent users, premature closure of growth plates, which can permanently reduce height.
Five main categories of prohibited substance: stimulants (alertness, reduce fatigue — sprint/combat sports); narcotic analgesics (mask pain — injury management); anabolic agents (muscle mass — power sports); diuretics (weight loss — weight-category sports); peptide hormones such as EPO (oxygen-carrying capacity — endurance sports).
Diuretics
Diuretics accelerate fluid loss through urine production. In weight-category sports such as boxing, judo or weightlifting, an athlete might use a diuretic in the days before weigh-in to shed enough fluid to compete in a lower weight category, gaining a size and strength advantage against smaller opponents. Diuretics are also sometimes misused to dilute urine samples, reducing the concentration of other banned substances and making them harder to detect. Side effects include dehydration, electrolyte imbalance, muscle cramps and, in severe cases, cardiac arrhythmia.
Peptide Hormones and EPO
Erythropoietin (EPO) is the most widely known peptide hormone misused in sport. Normally produced naturally by the kidneys in response to low oxygen levels (such as at altitude), EPO stimulates the production of red blood cells. More red blood cells means a greater capacity to carry oxygen to working muscles, which directly improves aerobic endurance performance. EPO has been widely associated with endurance cycling, cross-country skiing and distance running. Side effects include dangerous thickening of the blood (increased viscosity), which slows blood flow and increases the risk of blood clots, stroke and heart attack — particularly during sleep, when heart rate is low and blood flows slowly.
Blood doping achieves the same outcome as EPO — increased red blood cell count — through a different mechanism. An athlete removes a quantity of their own blood several weeks before competition. The body naturally replaces it. The stored blood is then frozen and re-infused just before the competition begins, producing an artificially elevated red blood cell count and enhanced oxygen-carrying capacity. The benefits are the same as EPO: improved aerobic endurance performance. The side effects are significant: the blood thickens after re-infusion (increased viscosity), which raises the risk of heart attack and stroke. There is also a serious risk of infection from contaminated equipment and the risk of an embolism (a blockage of a blood vessel by a clot or air bubble), which can be fatal.
Beta Blockers
Beta blockers are a distinct category of substance that are permitted in most sports but are restricted in a small number where fine motor control is critical to performance. They reduce heart rate, lower muscle tension and decrease blood pressure by blocking the effects of adrenaline. In sports requiring extreme precision — such as archery, shooting or snooker — a reduced heart rate and steadier hand provides a direct performance advantage. Side effects include nausea, weakness and potentially dangerous cardiac problems. Beta blockers should only be used under medical prescription; athletes using them without medical need in restricted sports face sanctions.
Blood doping and EPO both increase red blood cell count and oxygen-carrying capacity. Both cause dangerous thickening of the blood (increased viscosity), raising the risk of heart attack, stroke and embolism. Blood doping additionally carries risks of infection and embolism from the transfusion process.
Advantages and Disadvantages for Performers
The spec requires students to evaluate both sides of PED use from the performer’s perspective. The potential advantages include: an increased chance of winning; access to fame and financial rewards that success brings; and, where many competitors are doping, a perceived level playing field. The disadvantages are substantial and wide-ranging. Health risks range from liver damage to cardiac arrest and addiction. Detection leads to bans, fines and career destruction. Reputational damage can be permanent and extends to sponsors, national associations and fellow competitors who competed cleanly. For sport as a whole, high-profile doping scandals damage credibility and can reduce spectator interest and commercial revenue over time.
Some athletes have argued that if everyone is doping, using PEDs simply restores a level playing field. Students should be able to challenge this reasoning. First, not all athletes dope — those who refuse to do so are placed at a systematic disadvantage, which is not a level playing field. Second, access to the most effective and safest doping protocols depends on resources, meaning wealthier athletes and nations dope more safely and effectively than poorer ones — an inequality within the inequality. Third, the argument normalises a race to ever-higher levels of doping that accelerates health risks for all. A strong 9-mark answer will recognise the argument, acknowledge why it holds superficial appeal to performers, and then dismantle it with these counter-points.